AGL (Agilon Health) Piotroski F-Score: 2 (As of Jun. 26, 2026) — 50% Below Median


AGL Agilon Health Inc AGL
74 GF Score
Price $107.25
GF Value $94.48
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Agilon Health Piotroski F-Score?

Agilon Health AGL +0.27% 74 Piotroski F-Score is 2 as of Jun. 26, 2026, which is 50% below its 10-year median of 4.00. GuruFocus rates AGL with a GF Score™ of 74/100 and a GF Value™ of $94.48 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 652 Healthcare Providers & Services companies, Agilon Health ranks worse than 92.94% on this metric.

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Agilon Health has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Agilon Health's Piotroski F-Score or its related term are showing as below:

AGL' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 5
Current: 2

During the past 7 years, the highest Piotroski F-Score of Agilon Health was 5. The lowest was 2. And the median was 4.

Agilon Health  (NYSE:AGL) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Agilon Health Piotroski F-Score Related Terms


Agilon Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Agilon Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilon Health Piotroski F-Score Chart

Agilon Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 4.00 3.00 4.00 4.00 2.00

Agilon Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 4.00 2.00 2.00

AGL vs AVAH, HCSG, SNDA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Agilon Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilon Health Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Agilon Health's Piotroski F-Score falls into.


AGL
74GF Score
Agilon Health Inc AGL
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -104.37 + -110.207 + -188.882 + 48.916 = $-355 Mil.
Cash Flow from Operations was -35.085 + -18.154 + -20.537 + 23.728 = $-50 Mil.
Revenue was 1394.982 + 1435.321 + 1569.491 + 1420.46 = $5,820 Mil.
Gross Profit was -52.427 + -67.646 + -90.67 + 65.015 = $-146 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(1932.861 + 1712.895 + 1596.245 + 1271.29 + 1504.938) / 5 = $1603.6458 Mil.
Total Assets at the begining of this year (Mar25) was $1,933 Mil.
Long-Term Debt & Capital Lease Obligation was $19 Mil.
Total Current Assets was $1,321 Mil.
Total Current Liabilities was $1,272 Mil.
Net Income was -30.682 + -117.615 + -105.79 + 12.112 = $-242 Mil.

Revenue was 1482.758 + 1450.932 + 1522.486 + 1532.782 = $5,989 Mil.
Gross Profit was 32.175 + -64.167 + -38.255 + 50.722 = $-20 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(2316.463 + 2163.315 + 2091.411 + 1733.983 + 1932.861) / 5 = $2047.6066 Mil.
Total Assets at the begining of last year (Mar24) was $2,316 Mil.
Long-Term Debt & Capital Lease Obligation was $7 Mil.
Total Current Assets was $1,651 Mil.
Total Current Liabilities was $1,375 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Agilon Health's current Net Income (TTM) was -355. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Agilon Health's current Cash Flow from Operations (TTM) was -50. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-354.543/1932.861
=-0.18342912

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-241.975/2316.463
=-0.10445882

Agilon Health's return on assets of this year was -0.18342912. Agilon Health's return on assets of last year was -0.10445882. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Agilon Health's current Net Income (TTM) was -355. Agilon Health's current Cash Flow from Operations (TTM) was -50. ==> -50 > -355 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=18.654/1603.6458
=0.01163224

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=7.095/2047.6066
=0.00346502

Agilon Health's gearing of this year was 0.01163224. Agilon Health's gearing of last year was 0.00346502. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1321.173/1272.325
=1.03839271

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1650.722/1374.701
=1.20078621

Agilon Health's current ratio of this year was 1.03839271. Agilon Health's current ratio of last year was 1.20078621. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Agilon Health's number of shares in issue this year was 16.662. Agilon Health's number of shares in issue last year was 16.517. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-145.728/5820.254
=-0.02503808

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-19.525/5988.958
=-0.00326017

Agilon Health's gross margin of this year was -0.02503808. Agilon Health's gross margin of last year was -0.00326017. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=5820.254/1932.861
=3.01121188

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=5988.958/2316.463
=2.58538902

Agilon Health's asset turnover of this year was 3.01121188. Agilon Health's asset turnover of last year was 2.58538902. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Agilon Health has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 2 mean?
Agilon Health (AGL) has a Piotroski F-Score of 2 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Agilon Health and its competitors. This is 50% below median its historical median of 4.00. Over the past decade, Agilon Health's Piotroski F-Score has ranged from 2.00 to 5.00. According to the industry distribution chart, Agilon Health ranks #606 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 92.9%.
Is Agilon Health's Piotroski F-Score too high?
Agilon Health's current Piotroski F-Score of 2 is 50% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 5.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Agilon Health's value of 2 is 60% below this industry median. Based on the distribution chart, Agilon Health ranks #606 out of 652 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Agilon Health has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's Piotroski F-Score compare to AVAH and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #606 out of 652 companies for Piotroski F-Score. This places Agilon Health in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Agilon Health's value of 2 is 60% below this benchmark. Historically, Agilon Health's own Piotroski F-Score has ranged from 2.00 to 5.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Agilon Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilon Health's current Piotroski F-Score of 2 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Agilon Health and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilon Health's current Piotroski F-Score is 2, which is 50% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.48, compared to a current price of $107.25 — trading 13.5% above its estimated fair value. The current Piotroski F-Score is 2, which is 50% below median its 10-year median of 4.00 and 60% below the Healthcare Providers & Services industry median of 5.00. Agilon Health's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Agilon Health (AGL), the current Piotroski F-Score is 2 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilon Health (AGL) Overvalued in 2026?

Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued. The current stock price of $107.25 is trading 13.5% above its estimated GF Value™ of $94.48. GuruFocus considers Agilon Health to be Modestly Overvalued.

Key valuation signals for AGL:

  • Piotroski F-Score: 2 (50% below median its 10-year median of 4.00)
  • GF Value™: $94.48 vs. price of $107.25 (13.5% above fair value)
  • GF Score™: 74/100 with 7 warning signs
  • Industry Position: 60% below the Healthcare Providers & Services median (#606 of 652)

No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Agilon Health Business Description

Address 440 Polaris Parkway, Suite 550, Westerville, OH, USA, 43082
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
74GF Score

Get the complete analysis for AGL

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$107.25
Price
$94.48
GF Value